Literature DB >> 21367723

Peramivir: another tool for influenza treatment?

Seema Jain1, Alicia M Fry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21367723     DOI: 10.1093/cid/cir010

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  In Vitro Evaluation of Absorption Characteristics of Peramivir for Oral Delivery.

Authors:  Ying Li; Zhiyuan Wang; Xin Li; Wei Gong; Xiangyang Xie; Yang Yang; Wu Zhong; Aiping Zheng
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-10       Impact factor: 2.441

2.  Development of oseltamivir phosphonate congeners as anti-influenza agents.

Authors:  Ting-Jen R Cheng; Steven Weinheimer; E Bart Tarbet; Jia-Tsrong Jan; Yih-Shyun E Cheng; Jiun-Jie Shie; Chun-Lin Chen; Chih-An Chen; Wei-Che Hsieh; Pei-Wei Huang; Wen-Hao Lin; Shi-Yun Wang; Jim-Min Fang; Oliver Yoa-Pu Hu; Chi-Huey Wong
Journal:  J Med Chem       Date:  2012-10-12       Impact factor: 7.446

Review 3.  Safety and efficacy of peramivir for influenza treatment.

Authors:  Atsuko Hata; Ryoko Akashi-Ueda; Kazufumi Takamatsu; Takuro Matsumura
Journal:  Drug Des Devel Ther       Date:  2014-10-24       Impact factor: 4.162

Review 4.  Development of effective anti-influenza drugs: congeners and conjugates - a review.

Authors:  Jiun-Jie Shie; Jim-Min Fang
Journal:  J Biomed Sci       Date:  2019-10-23       Impact factor: 8.410

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.